X-Message-Number: 13906 Date: Sun, 11 Jun 2000 11:46:06 -0600 From: Fred Chamberlain <> Subject: Financing Suspensions, and LAST MINUTE ADDITION TO ASILOMAR Date: 6/11/2000 From: Fred Chamberlain Re: Kennita Watson's "Not Found" (Financing of Arrangements) Kennita: >David -- I looked for <http://www.alcor.org/crft17.hmt>http://www.alcor.org/crft17.hmt and it was >not found. Clever me tried .htm and .html; still nothing. >Help? >Thanks, >Kennita That's the problem with old URL's. Taking the link from Alcor's main page to "Library", and then to "Appendix C; Suspension Pricing and the Cost of Patient Care" will work better. The actual URL is: <http://www.alcor.org/CRFTnew/crft17.htm>http://www.alcor.org/CRFTnew/crft17 .htm The old CRFT17 is still up there, at: <http://www.alcor.org/crft17.txt>http://www.alcor.org/crft17.txt As the URL suggests, this is a crummy "text only" version, very hard to read, which is why all of the CRFT's were reformatted within the last year to match Alcor's current design by Derek Ryan. Browse the old one for comparison, if you want. We will probably delete it soon. It is no longer linked from the main site, so it's only there because it hasn't been swept away yet. The whole analysis of patient care will change as we integrate 21st Century Medicine, Inc.'s new cryoprotective formulas and freeze blockers into our protocols, and go to rapid cooldown where we drop straight down to -130F and then either stabilize there or follow a circuitous route to LN2. As an update on that, Alcor/BioTransport has signed confidentiality agreements with 21st CM which will permit the disclosure of the exact formulations of the newer cryoprotectants, and all of the components have been ordered, so that we can make these mixtures at Alcor. A licensing agreement is under negotiation, and is expected to be in final form before all of the components for the cryoprotectant mixture are delivered. A number of technology upgrades to Alcor's operating room equipment and cooldown systems are needed, but there will be ways to make use of these new compounds and carry out rapid cooldowns even as those upgrades are being made. I'll try to post notes on these upgrades to CryoNet as they take place. None of this would be possible without the financial support of BioTransport, Inc., which expects to assume responsibilities for Alcor's suspension procedures after the details of asset transfer and management are worked out. Meanwhile, by the terms of an earlier contract signed with Alcor in July, 1998, BioTransport is building technology toward that end result. LAST MINUTE ADDITION TO ASILOMAR SPEAKER LIST A separate notice could have been posted on this item, but it ties in with the comments (above) on BioTransport, so here it is. At the last minute, it has been possible to include Stephen Valentine's talk on the design and prospective development of what I have to think of, for all practical purposes as a "SUPERFACILITY". There's a better name for it, of course, and that is "TimeShip". If you go to Alcor's conference page at http://www.alcor.org/conf.htm, you'll see links to a very early conceptual drawing of Time Ship (the drawing actually has this as two separate words), plus a link to a synopsis of the talk at http://www.alcor.org/LET2000/tc.htm#superfacility and an overview of Stephen's professional background at http://<http://www.alcor.org/>www.alcor.org/LET2000/tc1.htm. He is scheduled to speak as the next to the last talk on Sunday Afternoon, as you'll see at http://<http://www.alcor.org/>www.alcor.org/LET2000/spkrsched.htm, we have extended his talk to 60 minutes, in view of the scope of the material, and dropped my talk on Bioimpedance. I'll be glad to discuss that (as well as BioTransport's redirection plan) with those attending, but Stephen's talk will be of far more general interest, I'm sure. Linda Chamberlain and I had a chance to hear Stephen Valentine speak on this subject in December, 1997, in Las Vegas, at a CryoCare annual meeting, just before the beginning of an A4M Conference. It is difficult to briefly describe the scope of what he has done, to explore the possibilities of a huge research and reanimation facility, which also has provisions for patient care (of up to 10,000 suspendees). Drawing on his background of participation in many large projects (see http://<http://www.alcor.org/>www.alcor.org/LET2000/tc1.htm), Stephen researched historical large man-made structures ranging from the Great Wall of China to the Pyramids. He combined current thinking on matters as diverse as vulnerability to natural and man made disasters with the goal of integrating libraries and research facilities into a structure also providing for patient storage. Two and a half years have now passed, since this initial presentation, and I have no doubt that Stephen's thinking has progressed a long way. At this point, he is selecting engineers for detailed design, and has secured the firm commitment of the people who financed Twenty First Century Medicine, Inc. to raise very large scale funding for his project. This is one presentation you don't want to miss, if there is still time for you to register for and attend Alcor's Asilomar Conference. Also, if you are planning to attend, I suggest you not head for the airport at noon on Sunday, or you'll "miss out"! Stephen will be available later in the evening to discuss his concept, as part of a multi-topic discussion of making membership arrangements (again, see the schedule at http://<http://www.alcor.org/>www.alcor.org/LET2000/tc1.htm, at the bottom of the table). Fred Chamberlain, President/CEO () Alcor Life Extension Foundation Non-profit cryonic suspension services since 1972. 7895 E. Acoma Dr., Suite 110, Scottsdale AZ 85260-6916 Phone (489) 905-1906 (877) 462-5267 FAX (480) 922-9027 for general requests http://<http://www.alcor.org/>www.alcor.org Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=13906